Fundação Hemoam

What Fundação Hemoam does

Fundação Hemoam (Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas) is a state government public foundation operating the sole public hematology and hemotherapy reference center for the State of Amazonas, Brazil. Founded in 1982 and headquartered in Manaus, the foundation provides integrated blood services — collection, processing, fractionation (red blood cell concentrate, platelet concentrate, plasma, cryoprecipitate), transfusion, and apheresis — alongside specialized treatment for hematological diseases including leukemia, hemophilia, sickle cell anemia, and thalassemia. It also operates the LAC clinical analysis laboratory, a bone marrow donor registry, and a CAPES-accredited Master's program in Applied Sciences to Hematology through partnership with the Universidade do Estado do Amazonas (UEA).

The foundation's technical infrastructure includes molecular biology laboratories (LABGEN) with PCR/RT-PCR capabilities, a six-color BD FACSCanto II flow cytometer, ELISA and cytogenetics platforms, and an ISO 9001:2000 certified quality management system covering the blood cycle. All services are delivered free of charge within the Brazilian Unified Health System (SUS), with revenue flowing from SUS reimbursements and direct allocations from the Government of Amazonas; patients access the foundation via SUS referral triage and walk-in blood donations. Blood products are distributed to public and private hospital networks in Manaus upon medical request.

A flagship capital expansion, the HEMOAM Hospital project (15,000 sqm, 157 beds, ICUs, imaging, and a bone marrow transplant center), was initiated in June 2014 under an initial R$49.8M budget, halted at roughly 30% completion in 2017, and resumed in January 2019 under a new R$39.8M contract with Construtora Mercure LTDA. The facility is designed to increase hematological care capacity approximately sixfold — from 900+ inpatients annually to over 5,000 — and to enable local bone marrow transplants, eliminating patient travel to São Paulo. Governance rests with the state government under Brazilian public administration law; the foundation has no private equity, venture, or external shareholders.

Name

Fundação Hemoam

Legal name

Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas

Website

https://hemoam.am.gov.br

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Fundação Hemoam is a public state foundation in Manaus, Brazil, operating the sole public hematology and hemotherapy reference center for Amazonas, providing blood collection, processing, transfusion, hematological disease treatment, clinical laboratory services, and graduate education within the SUS public health system.

Ownership category

akta.pro rank

Product category

Public Hematology and Hemotherapy Services

NAICS

Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

akta.pro secondary industries

Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Hematology & Coagulation Laboratories (HLAFAMAC), Medical Hematology (Benign Hematology) (HLAKAFAA)

Keywords

• Blood banking services
• Hematology treatment
• Clinical analysis laboratory
• Blood component fractionation
• Apheresis donation

Headquarters

HQ city

Manaus

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Supply Chain, Others

Revenue model

1. SUS (Unified Health System) Funding: As a public healthcare foundation, Hemoam operates primarily through funding from the Brazilian Unified Health System (SUS). Services are provided at no cost to patients, with expenses covered by government healthcare budgets. The foundation also receives resources from the Amazonas state government.
2. Blood Product Distribution: Blood and blood components are distributed to public and private hospital networks in Manaus upon medical request. This service is covered under SUS funding mechanisms.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Core offering

Fundação Hemoam is the public hematology and hemotherapy reference center for the State of Amazonas, providing the full blood cycle: voluntary blood collection (whole blood and apheresis), component fractionation, transfusion, clinical analysis, and specialized treatment of hematological diseases such as leukemia, hemophilia, sickle cell anemia, and thalassemia. It also runs emergency and inpatient services, a bone marrow donor registry, and CAPES-accredited graduate programs (Master's in Applied Hematology Sciences) and medical residency training. All services are delivered at no cost to patients through the Brazilian Unified Health System (SUS).

Product overview

Fundação Hemoam operates as a hematology and hemotherapy foundation providing integrated healthcare services in Amazonas, Brazil. The organization offers a unified portfolio centered around blood services, with core offerings including blood donation collection and processing (whole blood and apheresis), a comprehensive clinical analysis laboratory (LAC), specialized hematology treatment for conditions like leukemia and sickle cell disease, and emergency/inpatient hospitalization services. The foundation also maintains a bone marrow donor registry. Educational and research programs support the medical services through a Master's degree program in Hematology Sciences, medical residency, and scientific initiation projects. A major expansion project (HEMOAM Hospital) is underway to increase capacity sixfold.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood Donation Services
• LAC - Laboratory of Clinical Analyses

Quantifiable outcome

• Currently serves over 900 patients annually with 26 inpatient beds
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

14 partnerships are on record, tiered core and minor.

• Universidade do Estado do Amazonas (UEA)coreStrategic or Co-development Partner · 1 May 2012Partnership for the Master's Program in Applied Sciences to Hematology (PPGH-UEA/HEMOAM), credenciated by CAPES in 2012. UEA collaborates on developing specialization courses in Hemotherapy and Hematology and undergraduate specialization courses in Hematology and Clinical Analysis.
• Universidade Federal do Amazonas (UFAM)coreStrategic or Co-development PartnerCollaborates on the master's program with faculty members and participates in specialization courses in Hematology and Clinical Analysis. Also part of the PROCAD 2018 academic-scientific cooperation network for pathogen-host interaction research.
• Universidade Federal de São Paulo (UNIFESP)coreStrategic or Co-development PartnerTraining and qualification of human resources. UNIFESP helped consolidate the Cytogenetics and Histocompatibility Laboratories through staff qualification. Since 2012, institutions have been working on bone marrow transplantation. Eight masters were formed through the inter-institutional master's program in 2009.
• Universidade de Campinas (UNICAMP)coreStrategic or Co-development PartnerParticipates in the Brazilian Acute Leukemia Treatment Protocol (GBTLI) clinical trial through Instituto Boldrini. Faculty members contribute to the master's program. Part of PROCAD 2018 research network.
• Instituto BoldrinicoreStrategic or Co-development PartnerPediatric oncology reference center participating in clinical trials for the Brazilian Acute Leukemia Treatment Protocol (GBTLI) in partnership with UNICAMP and HEMOAM.
• Hospital Albert EinsteincoreStrategic or Co-development PartnerCollaboration in the Rare Red Blood Cell and Platelet Bank Program with the Ministry of Health, along with blood centers in Rio de Janeiro and Santa Catarina.
• Instituto Nacional de Câncer (INCA)coreStrategic or Co-development PartnerTechnical coordination of Brasil Cord Network, an initiative of the Ministry of Health for cord blood cell processing, with participation of 14 CPCs (Cell Processing Centers) across Brazil.
• Fundação de Medicina Tropical (FMT-HVD)coreStrategic or Co-development PartnerContributes faculty members to the master's program and participates in the genomic research network (LABGEN) with shared infrastructure in the Technology Park.
• Instituto Nacional de Cardiologia de LaranjeirasminorStrategic or Co-development PartnerCollaboration in multicenter study on cell therapy research.
• Universidade Federal do Pará (UFPA)coreStrategic or Co-development PartnerPart of the PROCAD 2018 academic-scientific cooperation network 'Academic cooperation network in pathogen-host interaction in the context of clinical hematology' together with UEA and UFAM.
• Instituto Nacional de Pesquisas da Amazônia (INPA)coreStrategic or Co-development PartnerContributes faculty members to the master's program and participates in the genomic research network.
• Universidade de GoiásminorStrategic or Co-development PartnerFaculty members from this institution contribute to the master's program in hematology.
• Universidade de São Paulo (FMUSP)minorStrategic or Co-development PartnerCollaboration to expand studies on COVID-19 and contribute relevant data about COVID-19 infection.
• Rede Brasil CordcoreStrategic or Co-development PartnerMinistry of Health initiative coordinated by INCA for cord blood cell processing, with 14 participating Cell Processing Centers (CPCs) in various Brazilian states including Belém, Brasília, Campinas, Curitiba, Fortaleza, Florianópolis, Porto Alegre, Recife, among others.

Scale indicators13 records

Recent moves10 records

Expansion highlights5 records

Broad incumbents

• American Red Cross Blood Services: Large U.S. blood collection and distribution operator serving hospitals and patients. Comparable core activity (blood collection, processing, fractionation, transfusion support) but operates on a donor-funded, non-profit commercial model rather than state-government public-health model.
• Hospital Israelita Albert Einstein: One of Brazil's leading private hospitals and a current Hemoam research partner on the Rare Red Blood Cell and Platelet Bank Program. Comparable on advanced hematology and laboratory capabilities, but operates a far broader multi-specialty portfolio under private and SUS funding.
• Instituto Nacional de Câncer (INCA): Brazil's national cancer institute, which already partners with Hemoam on the Brasil Cord Network and onco-hematology. Operates at a much broader scale across oncology, but overlaps on hematology and blood/cell banking, and would be a key referral destination if Hemoam's bone marrow transplant capability is delayed.
• Vitalant: Major U.S. non-profit blood collector and provider operating across multiple states. Comparable product line (whole blood and apheresis collection, fractionation into RBC/plasma/platelets/cryoprecipitate, hospital distribution) with similar regulatory and quality compliance demands.

Direct peers

• Fundação Pró-Sangue: São Paulo state blood center operating as the primary hemotherapy reference for Brazil's largest state. Same service portfolio (blood collection, processing, transfusion support) and SUS-aligned operations, but at significantly greater scale than Hemoam.
• Hemorio: Rio de Janeiro state blood center providing blood collection, processing, and hematology services under the same SUS/programs framework. Direct operational peer with overlapping service lines and similar regulatory posture.
• Hemoce: Ceará state hematology and hemotherapy center operating in the same Pró-Sangue national network with the same core blood banking and hematology services under SUS funding. Comparable mission and operating model.
• Fundação Hemope: Pernambuco state hematology/hemotherapy foundation offering the same core services as Hemoam (collection, fractionation, transfusion, hematology treatment) under the SUS framework, making it a structurally comparable regional reference center.
• Fundação Hemominas: State-level public hematology and hemotherapy foundation in Minas Gerais. Directly comparable as a fellow Pró-Sangue network member providing blood collection, processing, transfusion, and hematology treatment under SUS funding, with similar regulatory mandate and academic/research integration.

Regional players

• Hemoacre: Acre state hematology/hemotherapy center with the same Pró-Sangue mandate and core service set as Hemoam. Comparable structurally but smaller and focused on Acre — a neighboring Amazon-region state, making it both a peer and a potential referral partner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/FHemoam
• YouTubeyoutube.com/channel/UCnoEiKZIo-Fj_ZTcc5QEf2w
• Facebookfacebook.com/Hemoam
• Instagraminstagram.com/hemoam
• TikToktiktok.com/@fhemoam
• LinkedInlinkedin.com/company/hemoam

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundação Hemoam